Search

Search bills, members, committees and pages...

S. 272

U.S. SenateEngrossed

Summary

S. 272, the Protect Infant Formula from Contamination Act, was introduced in the Senate on Jan 28, 2025 by Sen. Gary Peters (D) with 9 co-sponsors. It last saw action on May 4, 2026: Held at the desk.


Record

Text

S. 272 has 9 co-sponsors.

sb272/engrossed-in-senate.txt
119 S272 ES: Protect Infant Formula from Contamination Act
U.S. Senate
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
119th CONGRESS 2d Session S. 272 IN THE SENATE OF THE UNITED STATES AN ACT
To improve the safety of infant formula through testing of infant formula for microorganisms, and for other purposes.
1.
Short title
This Act may be cited as the Protect Infant Formula from Contamination Act .
2.
Notifications for testing of infant formula
Section 412(e) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 350a(e) ) is amended—
(1)
in paragraph (1), in the matter following subparagraph (B)—
(A)
by striking promptly ;
(B)
by inserting , within 1 business day of acquiring such knowledge after such knowledge ; and
(C)
by striking the infant formula and inserting an infant formula ;
(2)
by redesignating paragraph (2) as paragraph (5); and
(3)
by inserting after paragraph (1) the following:
(2)
If the result of any testing of a sample from any production aggregate of finished infant formula product is confirmed as a positive analytical result for any microorganism for which finished product testing is required under section 106.55(e) of title 21, Code of Federal Regulations (or any successor regulation), the manufacturer shall—
(A)
within 1 business day of acquiring a confirmed positive analytical result, notify the Secretary of such result, regardless of whether such product has left an establishment subject to the control of the manufacturer;
(B)
promptly consult with the Secretary for proper isolation of the affected product, and, as the Secretary may require, cease distribution and properly dispose of the affected product; and
(C)
promptly provide to the Secretary results and isolates from a positive sample of such product or the whole genome sequence data from any confirmed positive analytical result.
(3)
Not later than 1 business day after receipt by the Secretary of a notification under paragraph (2)(A), the Secretary shall respond to the manufacturer of the infant formula to begin discussions regarding investigation and corrective action, and, as appropriate, share the findings of the Secretary with the manufacturer.
(4)
Not later than 90 days after receipt of a notification under paragraph (1) or (2), the Secretary shall confirm, including through the collection of documentation, that the manufacturer submitting the notification performed, or is performing, an appropriate investigation and corrective action, if applicable. The Secretary shall consider, as part of the review of the root cause investigation, the analytical method used to conduct laboratory testing and, as appropriate, the potential for cross contamination of the sample by handling and testing. The manufacturer shall make such documentation available to the Secretary electronically and for inspection under section 704.
.
3.
Reporting to improve the safety and supply of infant formula
Section 412 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 350a ) is amended by adding at the end the following:
(n)
Reporting To improve the safety and supply of infant formula
(1)
Progress report
Not later than 180 days after the date of enactment of the Protect Infant Formula from Contamination Act , the Secretary shall issue a progress report on implementation of the recommendations to improve the safety and supply of infant formula contained in the report titled, Long-Term National Strategy to Increase the Resiliency of the U.S. Infant Formula Market , issued by the Food and Drug Administration in January 2025. Such progress report shall include additional authorities or resources that the Secretary may require for purposes of improving the safety and supply of infant formula and any revisions to the recommendations as a result of any infant formula recalls since the publication of the report, as appropriate.
(2)
Quarterly reports on supply chain
Not later than 270 days after the date of enactment of the Protect Infant Formula from Contamination Act , and not less frequently than quarterly for the 5-year period thereafter, the Secretary shall submit a report on the most current critical supply chain data for infant formula, including in-stock rates, to—
(A)
the Committee on Health, Education, Labor, and Pensions; the Committee on Agriculture, Nutrition, and Forestry; and the Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies of the Committee on Appropriations of the Senate; and
(B)
the Committee on Energy and Commerce; the Committee on Agriculture; and the Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies of the Committee on Appropriations of the House of Representatives.
(3)
Consultation
The Secretary shall engage with the Department of Agriculture and other relevant agencies of the Federal Government regarding ongoing efforts to address immediate formula needs and build long-term resiliency into the infant formula market.
(4)
Reports on adequacy of supply
Not later than 1 year, 3 years, and 5 years after the date of enactment of the Protect Infant Formula from Contamination Act , the Secretary shall—
(A)
engage with public stakeholders, infant formula manufacturers, and other stakeholders, as determined by the Secretary, to determine evidence-based practices that can be implemented to maximize infant formula supply and infant safety, which may include the value of high frequency testing for purposes of identifying contamination events, including events associated with botulism or other contaminants, and bracketing potentially contaminated product, the impact of corrective action on contamination events, including events associated with botulism or other contaminants, and evidence-based recommendations for enhancing infant formula supply and safety; and
(B)
submit a report to the committees described in subparagraphs (A) and (B) of paragraph (2) that identifies the modifications to manufacturer practices and actions described in subparagraph (A), if any, that could be implemented to improve infant formula supply and safety.
.
Passed the Senate April 28, 2026. Secretary

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

  1. Introduced2025-01-28
  2. Passed Senate2026-04-28
  3. Passed House
  4. Conference
  5. To President
  6. Became Law

CRS Summary

The summaries are the Congressional Research Service’s, one per stage. Read them in full.

Introduced in Senate Jan 28, 2025

sb272/introduced-in-senate.md

Shown Here:
Introduced in Senate (01/28/2025)

Protect Infant Formula from Contamination Act

This bill imposes certain new requirements on infant formula manufacturers and the Food and Drug Administration (FDA) following the discovery of contaminated, adulterated, or misbranded infant formula.

Specifically, the bill requires infant formula manufacturers to report to the FDA within one business day of learning that formula that was processed by the manufacturer but that is no longer within the manufacturer’s control may not provide required nutrients or may be otherwise adulterated or misbranded.

Further, if any testing of finished infant formula reveals the presence of specified microorganisms (e.g., salmonella), the manufacturer must notify the FDA within one business day. (Under current law, manufacturers are only required to report contamination to the FDA if the affected formula has left the manufacturer’s control.) The manufacturer must also promptly provide the test results to the FDA and consult with the FDA on proper isolation and disposal of the affected product. The FDA must respond to such a notification and begin discussing proper investigative and corrective action with the manufacturer within one business day.

Within 90 days of a report of adulterated, misbranded, or contaminated infant formula, the FDA must determine whether the manufacturer that reported the problem has performed, or is performing, appropriate investigative and corrective action.

Finally, the FDA is required to periodically report on the infant formula supply chain and efforts to improve the safety and supply of infant formula, and must consult with other federal agencies and infant formula stakeholders on these issues.

Sponsors

Sen. Gary Peters (D) sponsors S. 272, and 9 members have co-sponsored it, 1 of them from the day it was introduced.

Committees

S. 272 went before 1 committee: Health, Education, Labor, and Pensions.

Health, Education, Labor, and Pensions
Health, Education, Labor, and Pensions
Reported By · Jan 28, 2026 · 747 Bills

Actions

S. 272 has taken 10 actions since Jan 28, 2025, the latest on May 4, 2026.

ChamberAction
May 4, 202610:32
House
Received in the House.
May 4, 202610:33
House
Held at the desk.
May 1, 2026
Senate
Message on Senate action sent to the House.
Apr 28, 2026
Senate
Passed Senate with an amendment and an amendment to the Title by Unanimous Consent. (consideration: CR S2074-2075; text: CR S2074)
Apr 28, 2026
Passed/agreed to in Senate: Passed Senate with an amendment and an amendment to the Title by Unanimous Consent.

Votes

S. 272 has not gone to a roll call.

Titles

S. 272 goes by 6 titles, 3 of them short titles.

  • Protect Infant Formula from Contamination Act — Display Title
  • A bill to improve the safety of infant formula through testing of infant formula for microorganisms, and for other purposes. — Official Titles as Amended by Senate
  • Protect Infant Formula from Contamination Act — Short Title(s) as Passed Senate
  • Protect Infant Formula from Contamination Act — Short Title(s) as Reported to Senate
  • Protect Infant Formula from Contamination Act — Short Title(s) as Introduced
  • A bill to improve the safety of infant formula through testing of infant formula for microorganisms and toxic elements, and for other purposes. — Official Title as Introduced

Cost estimate

The Congressional Budget Office has filed 1 estimate for S. 272, the latest on Mar 2, 2026.


Lobbying

4 clients hired 4 firms and 10 registered lobbyists who named S. 272 in 14 quarterly filings, 2025 to 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Agriculture, Budget/Appropriations, Health Issues, Taxation/Internal Revenue Code, Environment/Superfund, Food Industry (safety, labeling, etc.), Manufacturing, Transportation.

Clients

Who paid to be heard, by how many filings named the bill.

ClientBusinessStateFirmsFilingsReported
BOBBIE BABY, INC.Infant formula companyCalifornia16$300K
CONSUMER BRANDS ASSOCIATION (PKA: GROCERY MANUFACTURERS ASSOCIATION)Virginia14
NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERSNational professional association for pediatric nurse practitionersNew Jersey12$48K
FOOD MARKETPLACE INCVirginia12

Firms

Registrants who filed on the bill, by filings.

Lobbyists

Named on the filings that cite the bill.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

ClientRegistrantPeriodReportedDocument
CONSUMER BRANDS ASSOCIATION (PKA: GROCERY MANUFACTURERS ASSOCIATION)CONSUMER BRANDS ASSOCIATION (PKA: GROCERY MANUFACTURERS ASSOCIATION)2025 second_quarter$1.4M2nd Quarter - Amendme…
CONSUMER BRANDS ASSOCIATION (PKA: GROCERY MANUFACTURERS ASSOCIATION)CONSUMER BRANDS ASSOCIATION (PKA: GROCERY MANUFACTURERS ASSOCIATION)2025 first_quarter$715K1st Quarter - Amendme…
FOOD MARKETPLACE INCFOOD MARKETPLACE INC.2026 first_quarter$670K1st Quarter - Report
CONSUMER BRANDS ASSOCIATION (PKA: GROCERY MANUFACTURERS ASSOCIATION)CONSUMER BRANDS ASSOCIATION (PKA: GROCERY MANUFACTURERS ASSOCIATION)2025 first_quarter$615K1st Quarter - Amendme…
FOOD MARKETPLACE INCFOOD MARKETPLACE INC.2026 second_quarter$584K2nd Quarter - Report
CONSUMER BRANDS ASSOCIATION (PKA: GROCERY MANUFACTURERS ASSOCIATION)CONSUMER BRANDS ASSOCIATION (PKA: GROCERY MANUFACTURERS ASSOCIATION)2025 first_quarter$360K1st Quarter - Report
BOBBIE BABY, INC.CORBIN STRATEGIES LLC2026 second_quarter$50K2nd Quarter - Report
BOBBIE BABY, INC.CORBIN STRATEGIES LLC2026 first_quarter$50K1st Quarter - Report
BOBBIE BABY, INC.CORBIN STRATEGIES LLC2025 fourth_quarter$50K4th Quarter - Report
BOBBIE BABY, INC.CORBIN STRATEGIES LLC2025 third_quarter$50K3rd Quarter - Report
BOBBIE BABY, INC.CORBIN STRATEGIES LLC2025 second_quarter$50K2nd Quarter - Report
BOBBIE BABY, INC.CORBIN STRATEGIES LLC2025 first_quarter$50K1st Quarter - Report
NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERSMASON CONSULTING, LLC2026 second_quarter$24K2nd Quarter - Report
NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERSMASON CONSULTING, LLC2026 first_quarter$24K1st Quarter - Report

Classification

The Congressional Research Service files S. 272 under Health, one of its 31 policy areas, and gives it 8 legislative subjects.

CRS Subjects

CRS assigns every bill one policy area from its 31; S. 272’s is Health.

s272/policy-areas.txt
HealthAgriculture and FoodAnimalsArmed Forces and National SecurityArts, Culture, ReligionCivil Rights and Liberties, Minority IssuesCommerceCongressCrime and Law EnforcementEconomics and Public FinanceEducationEmergency ManagementEnergyEnvironmental ProtectionFamiliesFinance and Financial SectorForeign Trade and International FinanceGovernment Operations and PoliticsHousing and Community DevelopmentImmigrationInternational AffairsLabor and EmploymentLawNative AmericansPublic Lands and Natural ResourcesScience, Technology, CommunicationsSocial WelfareSports and RecreationTaxationTransportation and Public WorksWater Resources Development

Legislative Subjects

S. 272 carries 8 of CRS’s legislative subjects, from Child health to Supply chain.

s272/subjects.txt
Child healthCongressional oversightConsumer affairsFood supply, safety, and labelingGovernment information and archivesManufacturingNutrition and dietSupply chain

Source: congress.gov · legiscan.com